People · Operator
Named in public records as an officer, director or promoter · active 2017–2021 · Healthtech, Biotechnology, Other Health Care
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Imperative Care, Inc. | — | Healthtech | Series D+ | $584.7M | $712.6M | 2021 |
| Sonoma Biotherapeutics, Inc. | — | Biotechnology | Series D+ | $265.0M | $7.7B | 2021 |
| Atea Pharmaceuticals, Inc. | — | Biotechnology | Series D+ | $175.9M | $4.4B | 2018 |
| LoneStar Heart, Inc. | — | Other Health Care | Series A | $25.2M | $84.4M | 2017 |
Fan Yu at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Fan Yu on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Frank Yu | 2 | 3 |
| FARHAD KHOSRAVI | 1 | 14 |
| BIHUA CHEN | 1 | 14 |
| Olav B. Bergheim | 1 | 13 |
| Gerald Chan | 1 | 13 |
| Tara Butler | 1 | 12 |
| Franklin Berger | 1 | 7 |
| Henry Chen | 1 | 7 |
| Hugh B. Neuharth | 1 | 7 |
| Richard Klausner | 1 | 7 |
| Amar Sawhney | 1 | 6 |
| Raymond W. Cohen | 1 | 5 |
| Andrew Hack | 1 | 5 |
| Hank Plain | 1 | 5 |
| Evan S. Melrose | 1 | 5 |
| STACY ENXING SENG | 1 | 5 |
| CHARLES CHON | 1 | 5 |
| David Nikodem | 1 | 4 |
| Daniel Davis | 1 | 4 |
| Terry Rosen | 1 | 4 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.